Tag Archives: Eli Lilly and Company

Lilly To See Profit Decline Of Up to One-Third in 2014

Eli Lilly forecasts that its profit will fall by up to one-third this year, Reuters has reported. The company’s forecasted revenue for 2014 is now between $19.2 billion and $19.8 billion, with a net income of $3 billion and operating cash flow of $4 billion. The profit fall is in line with the company’s expectations, […]
Posted in Strategy | Also tagged , , , , | Leave a comment

Daiichi Sankyo Chief Talks Effient

FDA, late Friday, approved Daiichi Sankyo and Eli Lilly’s Effient (prasugrel), a blood thinner designed to lower the chance of blood clots in patients undergoing angioplasty. The drug received a black box warning from the get go, warning doctors of an increased risk of bleeding. However, the fact that the two companies now have a […]
Posted in News, Strategy, Technology | Also tagged , , , , , | 2 Comments

Amylin Drops 200 Sales Reps

Image via Wikipedia Biotech firm Amylin, on Monday, announced that it would trim its sales force by 200, or about 35 percent of its total. The move is expected to save the company about $65 million by 2010, and comes on the heels of an announcement that the company asked FDA to consider a once-weekly […]
Posted in Strategy | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta